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ABSTRACT 
Utilization of petroleum in consumer product manufacturing is causing irreversible 
environmental damage. Its impact on land, sea, and air calls for the development of more 
sustainable technologies based on the use of renewable materials such as lignocellulosic biomass 
and its conversion into platform chemicals. Engineering microorganisms to produce chemicals is 
an important undertaking to address such issues and bio-based production of adipic acid 
especially has gained recent attention. In the present thesis I assess the in vivo and in silico action 
of enzymes involved in microbial production of adipic acid from simple sugar molecules. The 
aim of this work was to comprehensively map out the metabolic pathways leading to adipic acid 
biosynthesis and to investigate the enzymatic components of the L-lysine pathway, the reverse β-
oxidation pathway, and cis,cis-muconic acid reduction.  
Investigation of theoretical and in silico aspects in the deamination step in the L-lysine 
pathway revealed deamination of L-lysine to be chemically difficult to occur. Removal of the β-
amino group from β-D-lysine was deemed more feasible than the α-amino group from L-lysine, 
and an alternative route via β-D-lysine deamination was suggested. Homology modeling and 
molecular docking studies shed light on the substrate binding mechanisms of enzymes 
responsible for the reduction of the intermediates in the L-lysine pathway. Potential mechanism 
and feasibility of α,β-reduction were explained in terms of substrate interaction in the enzyme-
binding pockets. Corynebacterium glutamicum was chosen as the host chassis for achieving 
adipic acid synthesis via reverse β-oxidation. Stepwise construction of a five-step synthetic 
pathway demonstrated functionality of each step in C. glutamicum. Biosynthesized and secreted 
3-hydroxyadipate was detected in the cultivation broth using GC/MS. Weak trans-2-hexenedioic 
acid and adipic acid signals were observed using LC/MS after concentrating the cultivation 
broth. Dehydration of 3-hydroxyadipyl-CoA was identified as a potential bottleneck in the 
pathway. While implementing the reverse β-oxidation pathway, a new pathway involving cis,cis-
muconic acid and 3-oxoadipic acid was identified and experimented on. The modified strategy 
for bio-conversion of benzoic acid to cis,cis-muconic acid was successful and molecular docking 
studies were carried out to better understand how oxidoreductases might reduce cis,cis-muconic 
acid. 
Taking multiple approaches to generate adipic acid revealed different challenges in each 
pathway. One approach led to biosynthesis of adipic acid.  
Keywords: Corynebacterium glutamicum, reverse β-oxidation, α,β-unsaturated bonds, β-D-
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“…And why do we fall, Bruce?  
So we can learn to pick ourselves up.” 
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Since the first genetically modified organism was reported in 1973 (Cohen et al. 1973; Cohen 
and Chang 1973), biotechnology has emerged as one of the most important tools to improve 
quality of life over the last half century. Owing to the power of recombinant DNA technology, 
production of the world’s first synthetic human insulin (Goeddel et al. 1979b) and the first 
recombinant drug, human growth hormone (Goeddel et al. 1979a), followed soon after. Over the 
next 50 years, the rapid development of biotechnology has not only allowed the establishment of 
routines to produce recombinant proteins (Baneyx 1999) and antibiotics (Hopwood et al. 1985), 
but has been applied also to vaccines (Slade et al. 2009), agriculture (Blancquaert et al. 2015), 
transgenic crops (Paine et al. 2005), and genetically modified animals (Jaenisch 1988). Given a 
growing awareness of air and ocean pollution, as well as man-made climate change, 
biotechnology has been employed to contribute to solve existing and upcoming environmental 
challenges (Zechendorf 1999), and achieve a more sustainable future (Griggs et al. 2013). In this 
thesis, the power of recombinant technology was applied to help address one of the greatest 
issues of my generation: petroleum dependency.  
One of the key contribution in addressing climate change and our reliance on fossil fuels 
is a continuous expansion of the catalogue of chemicals produced by genetically modified 
organisms (Straathof 2014), an important undertaking of industrial biotechnology (Erickson et 
al. 2012; Singh 2011). Genetic engineering of microorganisms allows facile manipulation of cell 
physiology and metabolism. In particular, the latter provides the opportunity to intentionally 
produce a desired metabolite or compound at high yield and productivity (Sauer et al. 2008). 
Depending on its chemical nature, the biologically produced compound may be compatible with 
existing petrochemical infrastructure and require only minor changes to downstream processes 
(Bozell 2010). The increased amount of omics data, along with better understanding of the 
genetic makeup of organisms, has facilitated the generation of more efficient and robust 
microorganisms (Brunk et al. 2016). The major motivation of my thesis work lies in the urgency 
to develop petroleum-independent adipic acid manufacturing.  
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Adipic acid, an aliphatic dicarboxylic acid, is used as a building block for fibers, 
polyesters, resins, and various polyamides including nylon-6,6 (Polen et al. 2013). Presently, 
industrial production of adipic acid relies on a mixture of cyclohexanone and cyclohexanol, also 
known as KA oil (ketone and alcohol), as feedstock (Van De Vyver and Román-Leshkov 2013). 
Oxidation of KA oil is achieved by employing nitric acid (HNO3) as oxidant, which emits nitrous 
oxide (N2O), a major contributor to global warming, and atmospheric pollution (Rahman et al. 
2016; Yan et al. 2020). KA oil is obtained from benzene, which is derived from petroleum 
(Rahman et al. 2016). An estimated 2.6–3.3 million tons of adipic acid is produced annually in 
the abovementioned manner (Kruyer et al. 2020; Polen et al. 2013). An estimated 65–80% of 
adipic acid is used in nylon-6,6 manufacturing for textiles, carpets, tires, and automobile parts 
(Polen et al. 2013; Shimizu et al. 2000).  
The dependence on petroleum during conventional adipic acid production and consequent 
negative environmental impact have sparked the search for more sustainable, bio-based 
alternatives. While multiple academic teams have explored and successfully carried out adipic 
acid biosynthesis (Figure 1 and paper I), technology transfer to the industry has been less 
effective (Babu et al. 2015; Cheong et al. 2016; Deng et al. 2016; Kallscheuer et al. 2017a; 
Kallscheuer et al. 2017b; Li et al. 2020; Yu et al. 2014). Successful examples of bio-based adipic 
acid biosynthesis by academic teams include the use of glycerol, which is neither a sugar nor of 
lignocellulosic origin, as a substrate (Zhao et al. 2018). Alternative production hosts, enzymes, 
and pathways are already available, yet remain underdeveloped. Ideally, successful bio-based 
adipic acid production involves efficient enzymes, a well-characterized biosynthetic pathway, a 
robust host, and a readily available production process.  
Initially, biological adipic acid production was preceded by the biosynthesis of cis,cis-
muconic acid (Niu et al. 2002) (Figure 2). cis,cis-Muconic acid biosynthesis had been the focus 
of research between the 1970s and 1990s (Tsuji and Kuwahara 1977), in part as an effort to 
understand biodegradation of aromatic compounds (Bang et al. 1996; Yoshikawa et al. 1990). 
Later on, the focus shifted toward production of cis,cis-muconic acid from glucose rather than 
aromatic compounds (Niu et al. 2002) and various strategies were attempted (Choi et al. 2020; 
Khalil et al. 2020; Kruyer and Peralta-Yahya 2017; Xie et al. 2014). Still, very little attention has 
been paid to biological conversion of cis,cis-muconic acid to adipic acid. Following the 
characterization of enoate reductase (Joo et al. 2017), the first biological production of adipic 
acid via cis,cis-muconic acid was reported (Raj et al. 2018).  
Research on biological production of adipic acid was then shifted to ω- and β-oxidation 
of fatty acid molecules (Beardslee and Picataggio 2012; Picataggio et al. 1991). The conversion 
begins with ω-oxidation of fatty acids by cytochrome P450 monooxygenase from Candida 
tropicalis ATCC 750 (Picataggio et al. 1992), aided by NADPH-cytochrome P450 
oxidoreductase (CPR) (Sutter et al. 1990). Dicarboxylic acids obtained by the ω-oxidation 
process can be subsequently shortened by β-oxidation (Figure 3). With fine-tuned β-oxidation, 
varying lengths of dicarboxylic acids can be selectively processed down to the six-carbon 
backbone molecule, adipic acid (Picataggio et al. 1991). Selectivity of dicarboxylic acid length 
can be adjusted by deletion of POX4, as the latter exhibits broad substrate specificity. The 
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overall process yields adipic acid from various fatty acid molecules and will be discussed in 




Figure 1. Overview of the metabolic pathways mediating direct production of adipic acid from 
glucose. Reverse adipate degradation pathway (blue lines), reverse β- then ω-oxidation pathway (red 
lines), 2-oxopimelic acid pathway (purple lines), 3-oxoadipic acid pathway (brown lines), 2-oxoadipic 
acid alternative pathway (yellow lines), lysine alternative pathway (green yellow). Enzymatic activity has 
been demonstrated for the steps indicated by full lines. Enzymes studied in papers II and III are 
highlighted in green. Enzymes studied in paper IV are highlighted in blue. Figure adapted from Figure 3 


















































































































































































































































































































































































































































































Figure 3. Production of adipic acid via ω- and β-oxidation of fatty acids. Conversion of a fatty acid 
(carboxylic acid) to dicarboxylic acid by means of the ω-oxidation pathway, followed by its entry in the 
β-oxidation cycle, whereby two carbons are lost per cycle until adipic acid is formed. Figure adapted from 
Figure 4 of paper I. 
 
 
The next wave of studies on biological adipic acid production centered on the reverse β-
oxidation pathways (Figure 1). Attempts to revert the functionality of β-oxidation were initially 
motivated by fuel biosynthesis (Dekishima et al. 2011; Dellomonaco et al. 2011). In subsequent 
years, the strategy was applied in various microorganisms to biosynthesize adipic acid from 
renewable feedstock, including glucose and glycerol (sections 4.2 and 5.5). Initial attempts to 
produce adipic acid from glucose using reverse β-oxidation proved to be challenging due to low 
titers (Babu et al. 2015; Cheong et al. 2016; Deng et al. 2016; Kallscheuer et al. 2017a; 
Kallscheuer et al. 2017b; Li et al. 2020; Yu et al. 2014) and the trend has shifted toward using 
glycerol owing to a possibly more favorable redox balance (Zhao et al. 2018). The enzymatic 
components for the reverse β-oxidation pathway were obtained from various organisms, as 
outlined in section 4.2. Because multiple enzyme options are available in each step of reverse β-




The overall goal of this thesis was to assess the individual enzymes involved in adipic 
acid biosynthesis via the L-lysine pathway, the reverse β-oxidation pathway, and cis,cis-muconic 
acid reduction (Figures 1 and 2). The L-lysine pathway has been theoretically conceptualized as 
a patent application (US Patent 7,799,545), but has not been experimentally demonstrated 
(section 4.1). Specifically, enzymes involved in the elimination of the α-amino group of L-lysine 
and subsequent reduction of the α,β-unsaturated bond of 6-amino-trans-2-hexenoic acid have not 
been well understood. Adipic acid biosynthesis from glucose via the reverse β-oxidation pathway 
is rather inefficient and has not been introduced yet in a microorganism with robust acid-
secretion capability (section 4.2). Moreover, the key factor determining the ability of 
oxidoreductases to reduce cis,cis-muconic acid has not been fully elucidated (section 4.3). In this 
thesis, I investigated enzymatic reactions involved in different synthetic pathways leading to 
adipic acid (paper I) by harnessing the potential of recombinant technology (paper IV and V), 
as well as in silico technologies (papers II, III and V) required to address the aforementioned 
issues. The intention was to improve our understanding of synthetic metabolism and building a 
foundation to develop cell factories capable of producing adipic acid from renewable resources 
such as simple sugars. The scientific questions raised during my thesis work and how I addressed 
them are listed below. 
 
Is adipic acid a naturally occurring compound?  
The natural occurrence of the target compound of this thesis, adipic acid, is considered rare 
(Polen et al. 2013); however, as it does occur in nature, its biosynthetic pathway can be 
identified and overproduction can be implemented in a designated host. Adipic acid has been 
detected in bacteria (Deng and Mao 2015), plants (Vavruch 1954), and patients with diabetic 
ketoacidosis (Pettersen et al. 1972). Whereas its biosynthetic pathway in plants has not been 
fully elucidated, the one in bacteria has been recently identified and can be engineered into other 
organisms. This raises the question of which genes and host organisms should be selected. Given 
the strong interest in bio-based adipic acid production, multiple pathways have been explored 
simultaneously by different research groups, further widening the options (paper I).  
 
Which adipic acid biosynthetic pathways are known, and which enzymatic steps are involved?  
A substantial effort to produce adipic acid from renewable feedstocks has already been made and 
numerous pathways have been identified (Averesch et al. 2018; Deng et al. 2016; Polen et al. 
2013) (paper I). The details of the individual enzymatic steps contributing to adipic acid 
biosynthesis (Figure 1) are addressed in paper I. Prior to the recent discovery of the bacterial 
pathway (Deng and Mao 2015), many groups introduced the reverse β-oxidation pathway in 
Escherichia coli (Babu et al. 2015; Cheong et al. 2016; Kallscheuer et al. 2017a; Yu et al. 2014). 
The enzymatic components for the reverse β-oxidation pathway were obtained from various 
organisms, as outlined in section 4.2. In my thesis, I approached the problem by first identifying 
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the enzymes for the reverse β-oxidation pathway (paper I) and then applying them in a 
combinatorial manner in Corynebacterium glutamicum (paper IV). 
 
Can a theoretical but unproven pathway be demonstrated?  
Although a bacterial adipic acid biosynthetic pathway has been discovered, it remains to be 
determined whether it is the most efficient and robust option. By exploring additional pathways, 
it may be possible to develop a superior one capable of using substrates other than glycerol. One 
such example is provided by the production of adipic acid via the L-lysine pathway (Figure 1). 
The L-lysine pathway remains solely theoretical because not all enzymatic steps have been 
identified. Removal of the α-amino group from L-lysine and subsequent reduction of the α,β-
unsaturated bond represent the ‘metabolic gap’ in the pathway (Shin et al. 2013), as all other 
metabolic steps between glucose and adipic acid are already known (papers I and II). The 
incomplete L-lysine pathway can be addressed both in theoretical and experimental terms. One 
can employ simulations to compute enzymatic steps and assess the thermodynamic feasibility 
and efficiency of the pathway. Experimentally, one can introduce a series of enzymes to build 
and then evaluate the pathways in vivo. Experimental aspects of the reduction and deamination 
reactions in the L-lysine pathway are addressed in papers II and III, respectively. Furthermore, 
interactions of enzymes and substrates in the L-lysine pathway are assessed in silico. As in silico 
studies shed light on enzyme-binding pockets and molecular interactions, this approach can be 
used to screen for possible enzyme candidates.  
 
Which organism is the most suitable for a given pathway?  
When multiple pathways are available, one can turn around the question and ask which pathway 
is most suitable for a given host organism. While yeast generally tolerates adipic acid better than 
bacteria (Karlsson et al. 2017), implementation of the cis,cis-muconic acid pathway (Raj et al. 
2018) or β-oxidation pathway in yeast does not yield more adipic acid than in E. coli. Even 
though E. coli has been shown to generate the highest adipic acid production (Zhao et al. 2018), 
the pathway should be further improved to allow for the use of substrates other than glycerol 
(paper I). Additionally, the pathway should be implemented in diverse host organisms to allow 
more options. The ideal production scheme would involve a robust, acid-tolerant strain and 
strong flux to adipic acid from glucose. I addressed this challenge in papers IV and V by 
investigating alternative combinations of pathways and production hosts. C. glutamicum presents 
interesting characteristics and, to the best of my knowledge, has not been reported previously as 
a production host for adipic acid. C. glutamicum is known to secrete multiple compounds 
including succinic acid and cis,cis-muconic acid under different conditions (section 5.4). Thus, 
paper IV provides in vivo feasibility assessment of reverse β-oxidation in C. glutamicum; 
whereas paper V investigates in vivo reduction of cis,cis-muconic acid in C. glutamicum 
(section 4.3).  
In general, developing a process for the bioproduction of chemicals from renewable 
feedstock often requires 1) pathway identification, 2) host selection, 3) implementation of 
individual enzymatic steps, 4) pathway and host organism optimization, and 5) process 
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optimization and scale-up (Shin et al. 2013). In my thesis, I addressed the first three steps. 












2. Computational assessment of 
enzyme-substrate interaction 
With advances in biotechnology, genome sequencing becomes cheaper with each year 
(Wetterstrand 2020) and nearly 9 trillion bases have been sequenced as of the end of 2020 (NCBI 
2020a). As a consequence of increasing genomic knowledge, the number of known protein 
sequences amounts now to nearly 200 million (EBI 2020; NCBI 2020b). For practical reasons, 
not all proteins can be crystallized; however, 11,000 crystal structures are reported annually and 
170,000 of them have been deposited by November of 2020 (RCSB 2020). At present, it is 
practically and realistically near to impossible to fully understand all the 200 million known 
protein sequences at the structural level. This is where computational tools prove to be powerful 
and useful in a complementary manner by broadening our knowledge of enzymatic processes. 
Homology modeling (Salmaso and Moro 2018) and molecular docking studies (Haddad et al. 
2020) have been particularly useful in this thesis for papers II and V. The computational 
methods ensured the substrate binding to the enzyme pocket during the enzyme candidate 
screening process.   
2.1. Protein structure prediction  
For practical reasons, structural studies and crystallography simply cannot keep up with the 
growing number of known protein sequences. To this end, homology modeling offers an 
important tool to complement structural studies as it allows to predict the 3D structure of a 
protein based solely on its sequence. Various tools are available for both academic and 
commercial purposes (Bordoli et al. 2009; Lindorff-Larsen et al. 2011; Misura et al. 2006; Yang 
et al. 2014). Besides differences between algorithms and software, there are also several methods 
to build a homology model, including physics-based modeling and knowledge-based modeling 
(Kuhlman and Bradley 2019). The latter is sometimes referred to as template-based modeling 
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and relies on existing knowledge about template structures, whereas the former uses 
conformational sampling and known examples of sequence homology to predict local structures.  
 The template-based approach depends on databases to identify both sequence and 
structural similarities. Protein structure databases such as PDB can be queried using the protein 
sequence of interest to find a suitable structural template for subsequent model construction. 
Structures can then be predicted based on multiple sequence alignment with the template 
sequences (Figure 4) (Bordoli et al. 2009; Eddy 1998). For instance, the alpha helices and beta 
sheets of an unknown protein can be constructed using already characterized structures with 
similar amino acid sequences. Multiple sequence alignment with BLAST, or equivalent, is done 
automatically in the homology modeling process. Because the template-based method relies 
heavily on sequence alignment, the structural coverage of a database and its accuracy are of 
crucial importance. As of 2017, nearly 70% of all human proteins and nearly 95% of all human 
drug targets had a structural homologue in the database (Somody et al. 2017). While the same 
level of coverage might not be true for all bacterial proteins, the proteins studied within the scope 
of this thesis each had at least one structural homologue as template (papers II and V). Novel 
protein folds were not discovered during the studies and thus their validation was not required. 
Proteins in this thesis exhibited strong homology with each template (87% identity for Oye and 
29-32% for enoate reductases). 
 
Figure 4. Exemplary multiple alignment of protein sequences. Members of the Old yellow enzyme 
family (labeled with PDB ID) and enoate reductases are aligned for comparison. Residues involved in 
substrate binding are highlighted in light green. The catalytic tyrosine residue is shown in magenta. 
Identical residues are highlighted black. Similar residues are highlighted in grey. E179 or equivalent 
residue unique to ERs is highlighted in cyan. E164 for E. coli 2,4-dienoyl CoA reductase (1PS9) involved 
in substrate binding is also highlighted in cyan. Conserved tyrosine residues prohibiting cis,cis-muconic 




Physics-based modeling can be useful when the sequence of interest does not present 
significant homology with other known globular structures. The algorithm looks for the lowest 
possible energy the protein structure conformation can take in the 3D space. In other words, 
given the amino acid sequence, the algorithm looks for the most stable 3D structure of the 
protein, i.e., that with the lowest energy conformation. Because the physics-based method does 
not rely on a database for homology search, novel folds are likely to be discovered (Kuhlman 
and Bradley 2019). Thus, it requires heavy computational power and shorter amino acid 
sequences are advantageous. Proteins with a length of 10–80 amino acids have been predicted 
with great accuracy using physics-based methods (Lindorff-Larsen et al. 2011). Given recent 
advances in computational power and machine learning capabilities, the prediction of protein 
structures has become even faster and more accurate (Callaway 2020). Artificial intelligence 
could successfully predict protein sequences of various lengths at the recent CASP 14 protein 
folding competition (Service 2020). For proteins studied in papers II and V, at least one 
template structure was identified, and the physics-based approach was not necessary. 
For all the homology models built during this thesis work, template-based methods were 
used. In paper II, the structure of NemA (E.C. 1.3.1.-) from E. coli was required but was not 
available from the database. Thus, a homology model was built using the Prime module in 
Maestro software. The template used for NemA model construction was pentaerythritol 
tetranitrate reductase (PDB: 3P7Y) (Toogood et al. 2011). The identities were 87% and the 
positives 94% between the NemA sequence and the template. In paper V, the structure of enoate 
reductases was required to study binding feasibility of cis,cis-muconic acid. As no such structure 
was available, homology models (Figure 5) were built using I-TASSER software (Yang et al. 
2014).  
2.2. Molecular docking  
Molecular docking applies computational tools to study the interaction between small molecules 
(e.g., substrates) and macromolecules (e.g., enzymes) (Morris et al. 1998; Trott and Olson 2009), 
and is widely used in chemistry and biology. Over the last two decades, computational tools 
including quantum mechanics and molecular docking have been crucial for protein and pathway 
engineering (Siegel et al. 2010; Wu et al. 2011; Zhang et al. 2008). While molecular docking is 
mainly used for drug discovery or structure-based drug design (Meng et al. 2012a; Morris et al. 
1998; de Ruyck et al. 2016), the technique is common also in metabolic pathway engineering 
and synthetic biology (Chen et al. 2016; Fisher et al. 2014; Li et al. 2016; Marcheschi et al. 
2012; Zhang et al. 2008). As a technique dealing with small molecule-protein interaction at the 
atomic level (Meng et al. 2012a; Morris et al. 1998), molecular docking can greatly assist in 
better understanding the enzymes to be implemented in pathway engineering. Molecular docking 






Figure 5. Exemplary homology modeling result. The enoate reductase homology model is shown in 
magenta. The template used for the model, 2-naphthoyl-CoA reductase (PDB: 6QKG) (Willistein et al. 
2019), is shown in deep blue. FAD, yellow; [4Fe-4S] cluster, orange; FMN, grey. Figure adapted from 
Figure S1 of paper V.  
 
In paper II, two target compounds, trans-2-hexenedioic acid and 6-amino-trans-2-
hexenoic acid, and two control compounds, trans-2-hexenal and trans-2-hexenoic acid, were 
used as substrates for docking to NemA and the Old yellow enzyme (Oye) family member Oye1 
(PDB: 1OYB) (Fox and Karplus 1994). The four substrates were constructed in a computational 
language and loaded in the docking software for preparation. Reduction of trans-2-hexenedioic 
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acid or 6-amino-trans-2-hexenoic acid had not been reported previously; here, it was attempted 
to increase knowledge of the L-lysine pathway (Figure 1). The rationale for choosing the L-
lysine pathway is discussed in more detail in a later chapter (section 4.1) as well as in paper II. 
Reduction of various α,β-unsaturated aldehydes (Stueckler et al. 2010), α,β-unsaturated 
ketoesters (Brenna et al. 2015), and α,β-unsaturated ketones (Brenna et al. 2015; Brenna et al. 
2013; Padhi et al. 2009) is well documented. The control compound trans-2-hexenal was chosen 
because it is a known substrate for members of the Oye family (Williams et al. 2004). Enzymatic 
reduction of a hexenoic acid is rarely described in the literature. Because the target molecules are 
bi-functional, the control compound trans-2-hexenoic acid was chosen to investigate the 
monocarboxylate functional group on a molecule with a 6-carbon backbone. The Oye family was 
specifically chosen due to its wide substrate specificity (Williams et al. 2004). Using such 
promiscuous enzyme was considered an advantage for studying an unknown reaction. Thus, 
molecular docking was performed prior to in vitro studies as part of the enzyme screening 
process in paper II. Had the enzymes not had binding pockets capable of accommodating the 
target substrates, they would have been omitted from further studies. The results obtained in 
paper II revealed that two of the Oye family members had binding pockets accommodating 
trans-2-hexenedioic acid or 6-amino-trans-2-hexenoic acid. Further insight on Oye members 
was gained in paper V, when they were compared to another family of enzymes. 
In paper V, the docking of two target compounds, cis,cis-muconic acid and trans-2-
hexenedioic acid, and one control compound, trans-cinnamic acid, (Figure 6) to Oye members 
and enoate reductase class of enzymes was studied. Given that trans-cinnamic acid is a known 
substrate for enoate reductases (Joo et al. 2017), it was used as the control. The initial aim of the 
molecular docking experiment in paper V was to identify whether significant differences among 
the binding residues of enoate reductases exist. Enoate reductases were previously described to 
be capable of reducing cis,cis-muconic acid and trans-2-hexenedioic acid (Joo et al. 2017); 
whereas Oye family members had been found incapable of reducing these two substrates (Joo et 
al. 2017). Nonetheless, Oye members were included in paper V because some of them bound to 
carboxylic acids in paper II. Moreover, additional members of the Oye members not covered in 
paper II were investigated in Paper V. Molecular docking in paper V showed that all enoate 
reductases and some Oye members could bind to the target substrates. However, the results also 
demonstrated clear structural differences among these two types of enzymes. For instance, 
whereas the binding pocket structure was similar among the two, the degree of solvent exposure 
was very different. Enoate reductases exhibit two α,β domains that are not present in Oye family 
members. More importantly, enoate reductases harbor a FAD and [4Fe-4S] cluster, which allow 
more reductive power compared to the Oye family. Additional minor differences in binding 
pocket residues, potentially capable of inhibiting carboxylic acid binding, were observed among 





Figure 6. Molecular docking of substrates to an enzyme model. Binding of (a) cinnamic acid, (b) 
cis,cis-muconic acid, and (c) hexenedioic acid to enoate reductase (magenta). Figure adapted from Figure 





3. Analytical methods for adipic acid 
pathway intermediates  
Chemical analysis is an important aspect in enzyme characterization and in vivo assessments of 
metabolic pathways. Metabolites present in low quantities are challenging to analyze especially 
when the amount is below the detection limit. Multiple analytical methods and instruments may 
be utilized in a complementary manner to provide better insight of the metabolic pathways. In 
papers VI and V, various analytical methods were used to evaluate metabolites in the cultivation 
broth. Producing non-native chemicals, which do not occur naturally in an organism, is 
challenging for numerous reasons. Heterologous gene expression does not always yield high 
intracellular protein levels and misfolded or insoluble products are common. Furthermore, the 
overall metabolism of the host organism might change as a result of introducing just a few genes. 
Sometimes, this goes unnoticed because the change is minor, yet, it shows that a powerful 
analytical method is needed to accurately detect target metabolites. Analytical methods to detect 
metabolites were extremely crucial in my studies to monitor the progression of the metabolic 
pathways.  
 
3.1. High-performance liquid chromatography 
High-performance liquid chromatography (HPLC) is commonly employed to measure various 
types of metabolites, including sugars, acetic acid, succinic acid, fumaric acid, and lactic acid. 
Here, HPLC was used in papers IV and V for metabolite analysis (Table 1). While compounds 
can be resolved easily by HPLC, the limit of detection is quite poor. The compounds listed above 
are often detected at a g/L scale and detection is feasible even at a mg/L scale; however, 
detection at a µg/L or ng/L scale is more problematic. In my case, the detection limit for adipic 
acid by HPLC being approximately 50 mg/L and production at the µg/L scale, HPLC was 
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employed in paper IV only to assess other compounds such as glucose. Additionally, HPLC was 
employed in paper V to analyze benzoic acid and cis,cis-muconic acid.  
 
Table 1. List of analytical methods used in this thesis to detect adipic acid pathway 
intermediates, adipic acid, sugars, and central metabolites.  
 Metabolites analyzed  Note 
HPLC Sugars, organic 
acids,  
central metabolites 
•Easy sample preparation  
 
•Signals within the detection range 
•Routine method available in the lab  
•Sensitivity not effected by cultivation broth 
 Benzoic acid and  
cis,cis-muconic acid 
•Easy sample preparation  
 
•Instrument operated with reverse phase column 
•Signals within the detection range 
 •Very high reproducibility  
 
Adipic acid •Current production level is lower than the detection limit  
•Derivatization needed for increased signal 
  •BPB derivatization step compromised by cultivation broth 
  •Instrument operated with a reverse phase column 




acid, adipic acid 
•MSTFA derivatization required 
 
•Very high sensitivity 
•Sensitivity compromised by cultivation broth 
 
•Removal of cultivation impurities desired 
•Requires staff for the instrument maintenance  
•Cultivation broth damages instrument 
 
•Currently only 3-hydroxyadipic acid production level within 
the detection range 
 •Qualitative result provided 
LC/MS 3-Oxoadipic acid and  
3-hydroxyadipic acid 
•Sensitivity compromised by cultivation broth  
 •Not compatible with the current SPE protocols 
 Trans-2-hexenedioic 
acid  
and adipic acid 
•Sample preparation is easy 
 •Analysis takes place at a different university 
 •Need logistics for sample transport  
 •Compatible with the current SPE protocols  
 
 
3.2. Gas chromatography/mass spectrometry  
Gas chromatography/mass spectrometry (GC/MS) is a widely used technique for identifying and 
quantifying compounds. The ability to provide qualitative confirmation of compounds present in 
the cultivation broth was the reason for choosing GC/MS as a means to further characterize the 
engineered strains in paper IV (Table 1). GC/MS can be used to identify or quantify compounds 
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within microorganisms for fluxome analysis (Wittmann et al., 2004), as well as those excreted 
by engineered microorganisms (Kallscheuer et al. 2017a). The target compound (adipic acid) and 
its intermediates were investigated in paper IV. The m/z fragmentation pattern can be used to 
identify the compound in the National Institute of Standards and Technology (NIST) database, 
while the instrument’s software provides the top 100 likely hits that match the fragmentation 
pattern, as well as their probability. Essentially, the probability defines the confidence level for a 
given compound based on the m/z fragmentation pattern, while the latter is then matched to the 
database. Because the library search is partially dependent on the peaks and fragmentation 
quality, the probability can be obtained also for each concentration of adipic acid standards. 
Here, the compounds of interest were functionalized by carboxylic acid and, hence, a 
derivatization step was needed to make the compounds more volatile and suitable for GC/MS 
analysis. To this end, the metabolites were derivatized by N-methyl-N-(trimethylsilyl)-
trifluoroacetamide (MSTFA) (Paczia et al., 2012). Given the uncertainty regarding the amount of 
the compound of interest present in the cultivation broth, the limit of detection of the GC/MS 
instrument was assessed first (Figure 7). Crucially, in GC/MS analysis, the signal corresponding 
to the target compound may be influenced by the presence of other chemicals such as the 
constituents of the cultivation broth. The purpose of limit of detection assessment was to detect a 
miniscule amount of adipic acid in the cultivation broth, which likely affected the obtained 
signals. Thus, the limit of detection was evaluated both in the absence and presence of 
cultivation broth. If the adipic acid standard matched the data library entry for adipic acid, then, 
increasing the concentration of standard should augment the chance of a match. This scenario 
was assessed with or without cultivation medium (Figure 7). In the absence of cultivation broth, 
even 1 µg/L adipic acid standard displayed 72% probability of matching the library entry. In 
contrast, in the presence of cultivation broth, spiking with 1 µg/L adipic acid led to only 1.17% 
probability (Figure 7). At 1 mg/L adipic acid, the probability of matching was 20% in the 
presence of cultivation broth and 95% in its absence. These results suggested that the presence of 
untreated cultivation broth posed a challenge when detecting less than 10 mg/L of adipic acid by 
GC/MS. This meant that the engineered strains had to be sufficiently efficient to produce 10 
mg/L or more of adipic acid if this method was to be employed.  
 
3.3. Carboxylic acid derivatization for reverse-phase HPLC 
Given the difficulty of measuring tiny concentrations of compounds by GC/MC in the presence 
of impurities, another approach was pursued. Because simply concentrating the samples would 
not be adequate, labeling and amplifying the signal of the target compound was deemed more 
appropriate. Even if not widely used, derivatization of free fatty acid molecules with 
chromophores, such as 4′-bromophenacyl bromide (BPB) (Durst et al. 1975; Grushka et al. 
1975; L’emeillat et al. 1981), 2-bromo-2′-acetonaphthone (Zhang et al. 2014) or 2-
bromoacetophenone (Grushka et al. 1975), have been documented before. Measurement of 
adipic acid below the level of detection by GC/MS was attempted using BPB derivatization. 
KOH served as the alkalizing agent and crown ether (18-crown-6) as catalyst. A successful 
measurement of adipic acid standard was accomplished (Figure 8), with 3.12 mg/L as the lowest 
reliably detected amount; below this level, peak shape and size became unclear (orange point, 
Figure 8). Construction of the standard curve for adipic acid in the presence of cultivation 
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medium was subsequently attempted; however, the signal did not correlate to the concentration 
of adipic acid and any attempts to measure sub-mg/L amounts of adipic acid were abandoned. 
Figure 7. Probability of the m/z fragmentation pattern matching the adipic acid entry in the library. 
The probability as a function of adipic acid standard concentration in the presence (dark square) or 
absence (empty circle) of cultivation medium is shown.  
Figure 8. Standard curve for BPB-derivatized adipic acid. The blue plot spans the range between 3.12 
and 50 mg/L adipic acid. The orange point corresponds to 1.56 mg/L adipic acid. 
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3.4. Solid-phase extraction 
Considering that the ratio of target compounds to interfering compounds was too low, selective 
sequestration of target analytes was needed. Thus, solid-phase extraction (SPE) was explored as 
a means of removing unwanted compounds from the cultivation broth and selectively extracting 
adipic acid or intermediate compounds. As all target compounds were derivatives of carboxylic 
acids, it was reasoned that ion exchange through an anionic column could be employed. 
However, all attempts to extract carboxylic acid from the cultivation broth based on anion 
exchange chromatography failed. Neither manipulation of SPE protocols according to the 
manufacturer’s guidance and suggestions, nor use of a counter-intuitive approach such as cation-
exchange column, improved the results. As the carboxylic acids were by no means retained in 
the resin columns, we hypothesized that the excessively high ionic strength of the cultivation 
broth prevented the correct interaction between the resin and carboxylic acids.  
Given that the target analytes were negatively charged, using a hydrophobic or non-
charged resin was not the most obvious option. However, the first evidence of successful 
carboxylic acid retention from the cultivation broth was actually observed with hydrophobic SPE 
resins (Appendix A). A hydrophobic column, Strata C8, was used initially to retain adipic acid 
and to remove impurities from the cultivation broth. Strata C8 is a silica-based resin 
functionalized by octane to enable hydrophobic interactions. At each step, SPE was modified to 
improve retention of adipic acid (Appendix A) based upon the assumption that the neutralized 
form of adipic acid was retained by the hydrophobic column in the presence of excessively high 
ionic strength or a more acidic pH, while impurities would flow through. Acidification of the 
cultivation broth prior to loading on the column ensured the neutralization of adipic acid. 
However, even under these conditions, adipic acid was not fully retained by the Strata C8 
column and was eluted in the load and wash fractions. For an accurate quantification, all adipic 
acid must be in the elution fraction. To try and improve retention, a different attempt was made 
by switching to another column called Strata X. While both columns interact with neutral 
compounds, the polymer-based Strata X resin retains compounds based on hydrophobic 
interactions and hydrogen bonding. Retention was substantially improved as no adipic acid was 
present either in the load or in the wash fractions when using the Strata X resin (Appendix A). 
As much as 5 mL of cultivation broth was loaded onto the SPE column, yielding a final elution 
volume of 1 mL and corresponding to a five-fold concentration. Not all impurities were removed 
by Strata X, but identification of flow through compounds was not pursued and the obtained 
result was deemed satisfactory. Retention was higher compared to the Strata C8 column even 
when the optimized protocols were applied (Figure 9). Testing with 100 µg of adipic acid, all 
adipic acid was recovered by Strata X while 83 µg by Strata C8. Additionally, retention of trans-
2-hexenedioic acid was successfully achieved by SPE (paper IV); whereas 3-hydroxyadipic acid




Figure 9. Adipic acid recovery by two different hydrophobic SPE columns. Adipic acid was spiked in 
the cultivation broth at a concentration of 100 mg/L. The recovery rate was normalized to that obtained by 
the Strata X resin. (N = 3; error bars = standard deviation).  
 
3.5. Liquid chromatography/mass spectrometry 
Based on the progress made with SPE, trans-2-hexenedioic acid was measured using liquid 
chromatography/mass spectrometry (LC/MS). It was assumed that both the target analytes and 
the impurities from cultivation broth were concentrated during the SPE process. Because of this 
increased amount of impurities, GC/MS was replaced by LC/MS to avoid damaging the 
instrument. Unlike GC/MS, the power of ionization is much lower and there is no fragmentation 
in LC/MS. However, dimers, adducts, and loss of water or carbon dioxide from the molecules 
may occur, yielding specific m/z patterns.  
LC/MS allowed to investigate the production of trans-2-hexenedioic acid in the 
engineered strains. Details about the construction of the strain for trans-2-hexenedioic acid are 
provided in paper IV. Cultivation broth from the engineered strain was collected and cells were 
removed by centrifugation and subsequent SPE treatment of supernatant followed. The Strata X 
column was loaded with 5 mL cultivation broth, which was concentrated to 1 mL by SPE. 5 µL 
of the sample was then analyzed by LC/MS for the presence of trans-2-hexenedioic acid (Figure 
10). The engineered strain, harboring plasmid pJS143, produced a miniscule amount of trans-2-
hexenedioic acid; whereas the latter compound was not detected in the control strain harboring 
plasmid pJS146 (paper IV). Plasmid pJS143 expressed four genes (paaJHF and tesB) and 
details of the metabolic pathway are described at a later point (section 4.2). The control plasmid 
expressed three genes (paaJH and tesB) from the same trans-2-hexenedioic acid biosynthesis 
pathway but lacked the one responsible for the last step (paaF). Further analysis with GC/MS 





Figure 10. Detection of trans-2-hexenedioic acid using LC/MS. Representative chromatograms of SPE-
treated samples are shown (extracted ion: 143.03498). The blue line indicates the trans-2-hexenedioic 
acid standard. Grey line indicates C. glutamicum harboring the trans-2-hexenedioic acid producing vector 
pJS143. Black line indicates C. glutamicum harboring 3-hydroxyadipic acid producing vector pJS146. 








4. Synthetic metabolic pathways for 
adipic acid production  
 
Multiple synthetic metabolic pathways for the biological production of adipic acid have been 
reported (Deng et al. 2016; Kallscheuer et al. 2017a; Kruyer and Peralta-Yahya 2017). While 
demonstration of a pathway’s functional status is a crucial step, further optimization and 
continuous improvements are necessary in order to augment the titer, yield, and productivity 
(paper I). Additionally, the use of glucose as feedstock for the biosynthesis of adipic acid 
requires further exploration and implementation of new strategies. While glycerol-based 
strategies for adipic acid biosynthesis has been successfully demonstrated, sugar-based substrates 
would permit transition opportunities toward lignocellulosic substrates. The L-lysine pathway 
(papers II and III), the reverse β-oxidation pathway (paper VI) and reduction of cis,cis-
muconic acid (paper V) were investigated in my thesis.  
 
4.1. Exploration of the L-lysine pathway  
Nearly a decade ago, US patent number 7,799,545 describing various synthetic pathways leading 
to adipic acid was published. The theoretical outline of adipic acid biosynthesis via L-lysine was 
first described in this patent. A handful of groups from academia and the industry have attempted 
to experimentally demonstrate the pathway (J.H. Seo, personal communications), but no success 
has been reported since then. Considering that L-lysine is a biologically and industrially 
attainable intermediate, the interest for this pathway remains.  
 Implementation of synthetic pathways in L-lysine-producing organisms is advantageous, 
given the industrial relevance of L-lysine and the estimated 2.4 million tons of it being produced 
annually (Lee and Wendisch 2017) by C. glutamicum fermentation. Biosynthesis of 1,5-
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diaminopentane (Kind et al. 2014; Kind and Wittmann 2011), glutaric acid (Rohles et al. 2018), 
and 5-aminovaleric acid (Rohles et al. 2016) has been successfully demonstrated by engineering 
L-lysine-producing strains. Any attempt to implement adipic acid production in L-lysine-
generating organisms is a logical approach as long as the pathways are well established (paper 
II). However, as adipic acid production via L-lysine has not been established, the biochemical 
and physical aspects of the pathway need to be explored prior to addressing current challenges. 
There are three biochemical steps in converting L-lysine to adipic acid: α,β-elimination, α,β-
reduction, and transamination at the ω-position. The transamination at the ω-position has already 
been addressed in the literature (Fedorchuk et al. 2020; Takehara et al. 2018; Yagi et al. 1991). 
 
 
Figure 11. The theoretical L-lysine pathways for adipic acid biosynthesis. (a) The L-lysine pathway 
to adipic acid first described by patent application U.S. 7,491,520 from Genomatica. (b) The alternative 
L-lysine pathway described in paper II. Figure adapted from Figures 1 and 2 of paper II. 
 
 The α,β-reduction step in the L-lysine pathway can occur either on trans-2-hexenedioic 
acid or on 6-amino-2-trans-hexenoic acid (Figure 11); the difference being whether α,β-
reduction happens before or after transamination of the terminal amino group. Reduction of 6-
amino-trans-2-hexenoic acid has been initially described in patent application U.S. 7,491,520 
(Raemakers-Franken et al. 2007); whereas reduction of trans-2-hexenedioic acid has not been 
detailed. To better understand the reaction mechanisms, molecular docking studies were carried 
out (paper II). To this end, it was first necessary to choose an enzyme structure. The crystal 
structure of Oye1 (PDB: 1OYB) from S. pastorianus had been often employed in computational 
studies of various α,β-unsaturated molecules (section 2.2). An additional enzyme, NemA from E. 
coli, was chosen for molecular docking studies, as it already showed activity toward 6-amino-
trans-2-hexenoic acid (Raemakers-Franken et al. 2007). Because a crystal structure for NemA 
was not available, a homology model was used instead. 
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Molecular docking studies revealed that both NemA and Oye1 possessed binding pockets 
large enough to accommodate 6-amino-trans-2-hexenoic acid or trans-2-hexenedioic acid 
(paper II). Binding of substrates to the enzyme occurred at an orientation and angle that were 
acceptable for catalysis during α,β-reduction. Subsequent purification of the enzymes was 
intended for experimental demonstration of the reduction reaction; however, in vitro experiments 
could not prove catalysis. One reason why the NemA result differed from a previous report 
(Raemakers-Franken et al. 2007) could be ascribed to different reaction conditions. Activation of 
the double bond is often required for α,β-reduction to occur (Lonsdale and Reetz 2015), and 
whether an Oye-type enzyme facilitates such activation on 6-amino-trans-2-hexenoic acid or 
trans-2-hexenedioic acid is unknown. While an experimental demonstration could not be 
provided, I was able to rule out the inability of the NemA or Oye1 enzymes to spatially 
accommodate trans-2-hexenedioic acid or 6-amino-trans-2-hexenoic acid (paper II). The next 
challenge would be to screen for more enzymes to identify those capable of performing the 
catalytic step. Once a possible candidate is selected in the future, mutation strategies can be 
devised to further improve catalysis. Along the course of this study, an enzyme capable of 
reducing trans-2-hexenedioic acid was reported (Joo et al. 2017). Furthermore, subjecting NemA 
to enzyme engineering could potentially improve its catalytic activity, which currently takes 48 h 
to detect (Raemakers-Franken et al. 2007). The discovery of new enzymes with which to carry 
out reduction may open new possibilities. Once the mechanisms of transamination and reduction 
are established, elimination of the α-amino group remains the only piece of the puzzle to be 
determined. A look at the synthetic pathway reveals that formation of 6-amino-trans-2-hexenoic 
acid or trans-2-hexenedioic acid follows removal of the α-amino group and a β-hydrogen to 
create an unsaturated bond between the α and β positions (Figure 11).  
 Removal of the α-amino group from L-lysine must be thoroughly examined in order to 
design a logical experimental strategy for adipic acid biosynthesis via the L-lysine pathway 
(paper III). One option would be oxidative deamination of the amino group, whereby the 
resulting molecule is an α-keto acid, which can be then converted to 6-aminocaproic acid via 
carbon elongation and subsequent decarboxylation (Cheng et al. 2019). The other option is non-
oxidative deamination, which theoretically leads to the formation of an unsaturated bond 
between α- and β-carbons. Arylalanine ammonia lyases, grouped under the E.C. 4.3.1.- category 
that includes histidine ammonia lyase and phenylalanine ammonia lyase, utilize 4-
methylideneimidazole-5-one (MIO) as a cofactor to catalyze the non-oxidative deamination 
(Poppe 2001; Schwede et al. 1999). Unlike L-phenylalanine or L-histidine, the L-lysine 
backbone lacks an aromatic ring and a nucleophile, thus making the MIO-catalyzed reaction on 
L-lysine appear chemically difficult. Additionally, as the mechanism of MIO-catalyzed 
deamination remains uncertain (Parmeggiani et al. 2018), it is unclear whether such reactions are 
suitable for elimination on L-lysine. Moreover, a hypothetical non-oxidative removal of the α-
amino group from L-lysine would proceed in conjunction with a base-catalyzed abstraction of 
the β-hydrogen (Figure 12). The acidity of β-hydrogen seems to be close to the weakest possible 
value and makes it very difficult to be abstracted (Bordwell 1988). To the best of my knowledge, 
no enzyme capable of carrying out such reaction on L-lysine has been reported. Indeed, such 
reaction seems nearly impossible on L-lysine unless the MIO-catalyzed reactions are ultimately 














































































































































































































By E1cB mechanism, an anion can be created on the β-position of L-lysine by base abstraction 
of the β-hydrogen (Parmeggiani et al. 2018). In E1 mechanism, a carbocation can be crated on 
the α-position of L-lysine by MIO departure. The E1 and E1cB are less likely to occur on L-
lysine by MIO catalyzed reaction due to unstable intermediate formation (Figure 12). Therefore, 
the desire to eliminate the α-amino group from L-lysine begs for a different strategy. 
 While elimination of the α-amino group from L-lysine seems chemically challenging, I 
hypothesize that replacing the amino group with a hydrogen in the β-position would facilitate the 
elimination reaction (paper III). In the hypothetical α,β-elimination of β-lysine, abstraction of 
the α-hydrogen yields a lone electron pair on the α-carbon, which can be stabilized by resonance 
through the α-carboxylate group (Porter and Bright 1980; Puthan Veetil et al. 2009). This would 
potentially allow for the formation of an enediolate intermediate, which would collapse to 
facilitate the departure of ammonia from the β-carbon. Abstraction of the β-hydrogen, followed 
by collapse of the enediolate intermediate has been shown to occur during non-oxidative 
deamination by L-aspartate ammonia lyase (Fibriansah et al. 2011; Shi et al. 1997). The 
structure of β-lysine and the hypothetical α,β-elimination of β-lysine resemble those of L-
aspartate (Figure 13). Structurally, the β-hydrogen in L-aspartate is in the α position to the 
terminal carboxylate and thus resembles the α-hydrogen in β-lysine. To have the elimination 
product in the trans conformation, β-lysine must be in the D-relative configuration and the side 
chain of β-D-lysine must be in the anti-position to the α-carboxylate in the reaction (Figure 14).  
 
 
Figure 13. Hypothetical base abstraction of the α-hydrogen in L-lysine and β-hydrogen in β-lysine. 
(a) An unstable lone-pair election results from base-abstraction of the β-hydrogen in L-lysine. (b) 
Hypothetical α,β-deamination of β-lysine via transient enediolate intermediate formation. (c) α,β-
elimination proceeds via the enediolate intermediate in L-aspartate ammonia lyase. B:, base; BH, 




The hypothetical elimination proceeds with initial abstraction of the pro-R proton of β-D-
lysine, followed by enediolate intermediate formation (Figures 13 and 14). A hypothetical 
enzyme would have suitable residues for stabilizing the enediolate intermediate. Collapse of the 
enediolate intermediate would then yield the elimination product of 6-amino-trans-2-hexenoic 
acid in the trans conformation. The need for a trans conformation can be rejected if α,β-reduction 
of 6-amino-hexenoic acid in the cis form is experimentally demonstrated. Regardless of the 
configuration of the product, the hypothetical α,β-elimination of β-lysine requires an engineered 
enzyme to be created (Figure 14). To the best of my knowledge, a naturally occurring enzyme 
capable of carrying out the elimination reaction on β-lysine has not been characterized nor 
identified. Aspects of the α,β-elimination theory on β-lysine, as well as trial experiments with 
aspartase-type enzymes are covered in paper III.  
 
 
Figure 14. Proposed enzyme binding mechanism to β-lysine by a hypothetical enzyme catalyzing 
α,β-elimination. Newman projection of substrates prior to abstraction of the β-hydrogen of (a) β-D-
lysine, (b) L-aspartate, and (c, d) L-lysine. The theoretical enzyme binding configuration and residues are 




4.2. Production of adipic acid and analogues via the reverse β-oxidation pathway 
Functional reverse β-oxidation for adipic acid biosynthesis was first implemented by engineering 
E. coli (Yu et al. 2014), with other examples following thereafter (Babu et al. 2015; Kallscheuer 
et al. 2017a; Zhao et al. 2018). Reverse β-oxidation utilizes intermediates in the central 
metabolism as building blocks to construct a 6-carbon backbone and to build adipic acid after a 
number of biotransformation steps. The first three steps of reverse β-oxidation are catalyzed by 
the same enzymes that are often involved in phenylacetate metabolism (Teufel et al. 2010). In 
the phenylacetate metabolism, metabolites enter the tricarboxylic (TCA) cycle after being 
converted to succinyl-CoA and acetyl-CoA. Instead, reverse β-oxidation, utilizes succinyl-CoA 
and acetyl-CoA as starting materials to drive the last three steps of phenylacetate metabolism in 
the opposite direction. The last step of phenylacetate metabolism is thiolytic cleavage of 3-
oxoadipyl-CoA (Teufel et al. 2010) and, therefore, the first step of reverse β-oxidation is a non-
decarboxylative Claisen condensation to form 3-oxoadipyl-CoA from succinyl-CoA and acetyl-
CoA (Cheong et al. 2016). A few enzymes are known to accomplish such condensation reaction 
(Table 2). Using E. coli as the host chassis, overexpression of 3-oxoadipyl-CoA thiolase (E.C. 
2.3.1.174) encoded by E. coli paaJ (Babu et al. 2015; Cheong et al. 2016; Kallscheuer et al. 
2017a; Yu et al. 2014) or its homolog encoded by Tfu_0875 from Thermobifida fusca (Zhao et 
al. 2018) achieved successful 3-oxoadiypl-CoA biosynthesis. T. fusca is also capable of carrying 
out the same reaction in vivo owing to the enzymatic activity of the Tfu_0875 gene product even 
at basal expression level (Deng and Mao 2015). In paper IV, overexpression of E. coli paaJ in 




Figure 15. Reverse β-oxidation for adipic acid biosynthesis from central metabolites. The synthetic 
pathway implemented in C. glutamicum is shown. PaaJ, 3-oxoadipyl-CoA thioase; PaaH, 3-
hydroxyadipyl-CoA dehydrogenase; PaaF, 2,3-dehydroadipyl-CoA hydratase; Ter, trans-enoyl-CoA 
reductase; TesB, acyl-CoA thioesterase. Figure adapted from Figure 1 of paper IV.  
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The second step of reverse β-oxidation is the reduction of 3-oxoadipyl-CoA to 3-
hydroxyadipyl-CoA. Reduction of 3-oxoadipyl-CoA can be carried out by various enzymes 
listed in Table 2. Overexpression of E. coli 3-hydroxyadipyl-CoA dehydrogenase (E.C. 
1.1.1.157) encoded by paaH from E. coli (Babu et al. 2015; Cheong et al. 2016; Kallscheuer et 
al. 2017a) or its Tfu_2399 homolog from T. fusca (Zhao et al. 2018), 3-hydroxyacyl-CoA 
reductase encoded by paaH1 from Ralstonia eutropha (Yu et al. 2014), or 3-hydroxybutyryl-
CoA reductase encoded by hbd from Clostridium acetobutylicum (Yu et al. 2014) has been 
reported to lead to reduction of 3-oxoadipyl-CoA in E. coli. Similarly, reduction of 3-oxoadipyl-
CoA (step 2 in Figure 15) has been achieved by implementing E. coli 3-hydroxyadipyl-CoA 
dehydrogenase in Pseudomonas putida (Niu et al. 2020) or C. glutamicum (paper IV).  
The next step is dehydration of 3-hydroxyadipyl-CoA to yield 2,3-dehydroadipyl-CoA 
(step 3 in Figure 15). Overexpression of the E. coli 2,3-dehydroadipyl-CoA hydratase gene in E. 
coli (Kallscheuer et al. 2017a) or P. putida (Niu et al. 2020) mediates this reaction and 2,3-
dehydroadipyl-CoA can be obtained (Table 2). The latter can be produced in E. coli also by 
overexpressing 3-hydroxyadipyl-CoA dehydrogenase encoded by Tfu_0067 from T. fusca, 
crotonase encoded by crt from C. acetobutylicum (Yu et al. 2014), putative enoyl-CoA hydratase 
encoded by ech from R. eutropha (Yu et al. 2014), or the gene product of paaZ from E. coli 
(Babu et al. 2015). Dehydration of 3-hydroxyadipyl-CoA through overexpression of E. coli 2,3-
dehydroadipyl-CoA hydratase in C. glutamicum could not be fully confirmed (paper IV). 
Release of CoA from 2,3-dehydroadipyl-CoA yields trans-2-hexenedioic acid. While a miniscule 
amount of trans-2-hexenedioic acid was observed by LC/MS (Figure 10), another method, such 
as GC/MS or LC with tandem MS (LC-MS/MS), is required to confirm the presence of this 
byproduct. 
Reduction of 2,3-dehydroadipyl-CoA (step 4 in Figure 15; Table 2) yields adipyl-CoA. 
This can be accomplished by overexpression of trans-enoyl-CoA reductase encoded by ter from 
Treponema denticola (Cheong et al. 2016), bcd from C. acetobutylicum (Babu et al. 2015), 5-
carboxy-2-pentenoyl-CoA reductase encoded by Tfu_1647 from T. fusca (Zhao et al. 2018), 
trans-enoyl-CoA reductase from Euglena gracilis (Dekishima et al. 2011; Yu et al. 2014), or 
dcaA from Acinetobacter baylyi (Kallscheuer et al. 2017a) in E. coli. In the final step, release of 
CoA from adipyl-CoA yields adipic acid (step 5 in Figure 15). Overexpression of acyl-CoA 
thioesterase (Acot8) from Mus musculus (Babu et al. 2015; Cheong et al. 2016), its homolog 
from A. baylyi (Kallscheuer et al. 2017a), or succinyl-CoA synthetase (Tfu_2577, Tfu_2576) 
from T. fusca has been shown to release adipic acid from adipyl-CoA in E. coli (Table 2).  
Overexpression of paaJ, paaH, and tesB in C. glutamicum grown in shake-flasks allowed 
for 3-hydroxyadipic acid biosynthesis and its detection following excretion from the cell (paper 
IV). Derivatizing the samples and subjecting them to GC/MS analysis would provide insight on 
the formation of pathway intermediates. Detection of chemically derivatized 3-hydroxyadipic 
acid was an encouraging result as it proved that part of the pathway was functional. Non-
decarboxylative Claisen condensation of acetyl-CoA and succinyl-CoA to form 3-oxoadipyl-
CoA, reduction of 3-oxoadipyl-CoA, and finally release of CoA to form 3-hydroxyadipic acid 





Figure 16. Fragmentation pattern of trimethylsilylated 3-hydroxyadipic acid biosynthesized by 
engineered C. glutamicum. The engineered strain harboring paaJ, paaH, and tesB was cultivated in 
shake-flasks. Cell-free cultivation broth was chemically derivatized and analyzed by GC/MS. Inset shows 
MSTFA-derivatized 3-hydroxyadipic acid NIST database entry. Figure adapted from Figure 2 of paper 
IV. 
 
The 3-hydroxyadipic acid precursor can be converted to adipic acid either biologically or 
chemically (Shi et al. 2020). Additionally, it can co-polymerize with other monomers to form 
various non-traditional polyesters and polyamides. 3-Hydroxyadipic acid synthesis requires 
heavy metals and strong acids (Shi et al. 2020). In comparison, the method described in my 
thesis relied on an engineered microorganism as the biocatalyst and simple sugar as the starting 
material (paper IV). Introduction of the downstream genes paaF and ter to the parental strain 
did not yield convincing amounts of trans-2-hexenedioic acid (Figure 10) nor adipic acid 
(Figure 17). However, detection of a small amount of adipic acid in the cultivation broth was 
possible after SPE treatment of samples prior to LC/MS analysis. Again, a more sensitive 
method, such as GC/MS or LC-MS/MS, would further verify the identity of adipic acid in the 






Figure 17. Adipic acid detection by LC/MS. SPE-treated cultivation broth of engineered C. glutamicum 
strains was analyzed by LC/MS (extracted ion: 145.05063). Representative chromatograms from triplicate 
data are shown. Purple line: adipic acid standard. Green line: C. glutamicum harboring the adipic acid-
producing vector pJS133. Grey line: C. glutamicum harboring the trans-2-hexenedioic acid producing 
vector pJS143. Black line: C. glutamicum harboring an empty vector. Figure adapted from paper IV. 
 
Prominence of 3-hydroxyadipic acid, together with only small amounts of trans-2-
hexenedioic acid and adipic acid, in the cultivation broth of the strain harboring the full-length 
pathway pointed to a possible bottleneck caused by the inefficient dehydration of 3-
hydroxyadipyl-CoA to 2,3-dehydroadipyl-CoA (paper IV). In the design of the full-length 
vector, pJS133, paaJ and paaF genes were organized in an operon with paaF downstream of 
paaJ. Downstream genes are known to be expressed more weakly than upstream genes in operon 
configurations (Lim et al. 2011). To ensure stronger flux from 3-hydroxyadipyl-CoA to 2,3-
dehydroadipyl-CoA, stronger expression of paaF was needed. Optimized codon usage has been 
demonstrated to improve protein expression as well as the synthetic pathway metabolic flux 
(Shin et al. 2016). Assessment of codon bias of the constructs revealed some discrepancy with 
the codon usage in C. glutamicum (Figure 18). To improve pathway flux and overcome the 
bottleneck, a new plasmid vector with optimized codon usage was constructed, transformed into 
C. glutamicum, and evaluated by flask-cultivation. As the C. glutamicum harboring the improved 
vector failed to increase the amount of adipic acid, there is likely another reason for the 
inefficient conversion of 3-hydroxyadipyl-CoA to 2,3-dehydroadipyl-CoA in C. glutamicum. 
The effect of codon change in PaaF can be investigated more in detail by either individual 
protein assessment or re-organizing the operon and placing a promoter directly upstream of paaF 






Figure 18. Codon usage analysis of genes in the adipic acid vector. The codon usage pattern of five 
genes involved in adipic acid production is shown (codon 1). The codon usage pattern in the C. 
glutamicum genome was analyzed from two databases, including RefSeq and Kazusa. A different plasmid 
vector for producing adipic acid was constructed in agreement with the codon usage pattern from the 
above databases (codon 2). Codons ending with G and C are organized on the left side of the heatmap. 
Stop codons, start codons, and the tryptophan codon are omitted for clarity. 
 
4.3. Evaluation of cis,cis-muconic acid reduction in C. glutamicum 
One of the most notable examples in bio-based adipic acid production involves the generation of 
cis,cis-muconic acid from glucose by engineered E. coli (Draths and Frost 1994). Because this 
engineering strategy relied on the protocatechuic acid pathway, absence of shikimate 
dehydrogenase (E.C. 1.1.1.25; encoded by aroE) was required to accumulate 3-dehydroshikimic 
acid. Further introduction of dehydroshikimate dehydratase (E.C. 4.2.1.118; encoded by aroZ) 
and protocatechuate decarboxylase (E.C. 4.1.1.63; encoded by aroY), both from Klebsiella 
pneumoniae, allowed carbon flux in the engineered E. coli to proceed to catechol. Finally, 
introduction of Acinetobacter calcoaceticus catechol 1,2-dioxygenase (E.C. 1.13.11.1; encoded 
by catA) enabled production of cis,cis-muconic acid from glucose. A study encompassing more 
genetic engineering and process engineering steps was published later on (Niu et al. 2002). As 
mentioned earlier in the introduction of this thesis and in paper I, many other studies followed 
and the biosynthesis of cis,cis-muconic acid has been extensively investigated. Most studies have 
focused on chemical catalysis for the conversion of cis,cis-muconic acid to adipic acid.  
While it has been long speculated that enzymatic reduction of cis,cis-muconic acid would 
be possible, it was considered a challenge because many enzymes capable of such reduction 
depended on a Fe-S cluster and required an anaerobic environment. Many bioprocesses affecting 
cis,cis-muconic acid are aerobic as degradation of aromatic compounds requires oxidation 
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(papers I and V). While enoate reductases from Clostridium species have been considered as 
feasible candidates, they are oxygen-sensitive. A breakthrough occurred in 2017, when oxygen-
tolerant enoate reductases were reported to reduce cis,cis-muconic acid (Joo et al. 2017). 
Particularly, enoate reductase from Bacillus coagulans or C. acetobutylicum not only reduced 
cis,cis-muconic acid, but reduced also trans-2-hexenedioic acid to adipic acid; whereas enzymes 
belonging to the Oye family were not able to catalyze the same reduction steps. Because the 
reasons for such reaction disparity were not provided in that study, I have investigated the 
differences between Oye members and enoate reductases (paper V). Molecular docking of 
cis,cis-muconic acid or trans-2-hexenedioic acid to enoate reductases from B. coagulans, C. 
acetobutylicum, Clostridium kluyveri, Clostridium ljungdahlii, and Moorella thermoacetica 
proceeded in a seamless way. Interestingly, not all members of the Oye family were able to 
accommodate cis,cis-muconic acid or trans-2-hexenedioic acid, as some of them did not possess 
a pocket shape that would correctly fit cis,cis-muconic acid for reduction (Supplementary 
information in paper V). Further, it was found that enoate reductases were much larger than Oye 
members and there was only homology between the enoate reductases and the TIM barrel 
domain of Oye members. Additionally, the enzyme pocket of Oye members was much more 
exposed to the solvent; whereas that of enoate reductases was buried deeply inside. It was further 
speculated that the FAD cofactor-binding domain was displayed only by enoate reductases and 
not Oye family members.  
 
4.4. Conclusions on synthetic pathways for adipic acid biosynthesis  
Multiple pathways exist for adipic acid biosynthesis, and each is met with different challenges. 
Properly functioning L-lysine pathway would allow adipic acid biosynthesis from glucose when 
the pathway is introduced into a L-lysine overproducing microorganism. However, a metabolic 
gap exists in the pathway since not all steps have been well characterized. Examining the MIO 
catalyzed reactions revealed that mechanism via E2 is likely necessary for deamination of L-
lysine. If the MIO-catalysis does not proceed via E2, then focus should shift to an alternative 
pathway via β-D-lysine.  
Since adipic acid production from glucose with reverse β-oxidation pathway has not been 
efficient in E. coli, C. glutamicum was explored and adipic acid biosynthesis was demonstrated. 
While further engineering must be done to improved titer, a weak signal was observed and 
indirectly indicated that the pathway was functioning.  
Molecular docking studies of oxidoreductases revealed that enoate reductases instead of 
Oye members should be investigated for follow up studies. The enoate reductase have the 
cofactors and sufficient reducing power for reduction of cis,cis-muconic acid and trans-2-






5. Host chassis for adipic acid 
biosynthesis 
While E. coli and S. cerevisiae are often employed for genetic manipulation, they are not always 
the best choice for producing the desired compound(s). Each microorganism has adapted to its 
own niche and has developed different characteristics and capabilities. Choosing the correct host 
strain is as important as choosing the right enzymes and pathways (paper I).  
 
5.1. Yeast  
Yeasts are some of the model organisms most often selected for genetic manipulation, and 
production of adipic acid in yeast has been contemplated by both academic and industrial 
laboratories (Beardslee and Picataggio 2012; Picataggio et al. 1992; Raj et al. 2018; Sandström 
et al. 2014). Verdezyne, one of the most anticipated adipic acid biotechnology companies of the 
past decade, attempted to produce adipic acid from palm oil feedstock (Beardslee and Picataggio 
2012). The host organism was Candida tropicalis and the technology was built upon ω-oxidation 
of fatty acids (Picataggio et al. 1992). In the laboratory, this approach was demonstrated using 
coconut oil as feedstock (Beardslee and Picataggio 2012); whereas in industrial settings, 
implementation was based on crude palm oil. Having demonstrated a 50 g/L titer of adipic acid 
(Beardslee and Picataggio 2012), a new pilot plant was nearly 80–85% complete when the 
project was unfortunately discontinued (paper I). Although this event clearly reflected the 
challenges of bio-based production, efforts to produce adipic acid continued within academia (Ju 
et al. 2020). Taking a different approach, an engineered S. cerevisiae strain was shown to 
produce adipic acid via the cis,cis-muconic acid pathway using glucose as feedstock (Raj et al. 
2018). While production of cis,cis-muconic acid from renewable feedstock had been 
demonstrated multiple times, its conversion to adipic acid had relied heavily on chemical 
processes. Eventually, Mahadevan and colleagues discovered an enoate reductase (Joo et al. 
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2017) and implemented it in S. cerevisiae for successful production of adipic acid. While the titer 
remains at the sub-g/L scale, this example demonstrates ongoing efforts to develop petroleum-
independent production of adipic acid. Shifting between aerobic and anaerobic phases during 
cultivation, as was done in that study (Joo et al. 2017), could potentially overcome the enoate 
reductase inactivity observed in paper V.  
 
5.2. Thermobifida 
Even though adipic acid occurs rarely in nature, a microbial pathway that produced adipic acid 
was first reported in T. fusca in 2015 (Deng and Mao 2015). This metabolic pathway was 
observed while trying to produce 1-propanol (Deng and Fong 2011) and was identified as reverse 
β-oxidation. It consisted of five biochemical steps starting from the central metabolism and 
involved six genes: Tfu_0875, Tfu_2399, Tfu_0067, Tfu_1647, Tfu_2577, and Tfu_2576. 
Implementing the Tfu_0067 gene in C. glutamicum could address the bottleneck caused by the 
dehydration reaction in paper IV. The above six genes were later implemented in E. coli where 
they further improved adipic acid biosynthesis (Zhao et al. 2018). 
 
5.3. Pseudomonads 
Pseudomonas putida and other Pseudomonads have been known to carry out soil detoxification 
and bioremediation through degradation of aromatic compounds. Production of cis,cis-muconic 
acid has been a notable example of the application of P. putida. Niu and colleagues, who 
pioneered the engineering of E. coli for cis,cis-muconic acid production, have recently succeeded 
in generating adipic acid from engineered P. putida (Niu et al. 2020). The starting aromatic 
compounds, including protocatechuic acid and catechol, were converted to 3-ketoadipic acid via 
cis,cis-muconic acid. Specifically, 3-ketoadipic acid was converted via the reverse degradation 
pathway in a manner akin to that described in paper IV. A similar approach was attempted 
during preliminary studies carried out in paper V, whereby strains developed in paper IV were 
tested for their capacity to convert benzoic acid to adipic acid.  
 
5.4. Corynebacterium 
A growing wealth of genomic knowledge has allowed to move beyond traditional model 
organisms, such as E. coli and S. cerevisiae, to more diverse targets. As a result, C. glutamicum 
has become one of the most well characterized model organisms for metabolic engineering 
(Becker and Wittmann 2015; Becker and Wittmann 2012; Lee et al. 2016). Originally discovered 
in Japan, C. glutamicum has been used as a workhorse for the production of amino acids for 
more than half of the previous century. Indeed, global production of L-glutamate and L-lysine 
for the food industry relies mainly on C. glutamicum, which generates 2.4 million tons of L-
lysine and 3.1 million tons of L-glutamate annually (Lee and Wendisch 2017). Rational 
engineering of C. glutamicum for dietary supplement production has been mostly avoided, 
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perhaps due to regulation concerning the use of GRAS organisms. In the industry, strain 
improvement has been based mostly on random mutagenic methods followed by massive 
screening. In contrast, in academia, the preferred approach has been that of selective genetic 
engineering.  
Another reason for the establishment of C. glutamicum in academic research could be 
linked to its exceptional capability to overproduce primary metabolites. Genetic engineering or 
process engineering strategies have been applied to C. glutamicum to separately produce 
enormous amounts of primary metabolites and amino acids, including succinic acid, L-ornithine 
(Meiswinkel et al. 2013), L-arginine, L-glutamate (Yang et al. 2015), L-lysine (Becker et al. 
2011), L-alanine (Yamamoto et al. 2012), L-valine (Hasegawa et al. 2012), ethanol (Inui et al. 
2005), L-lactate (Tsuge et al. 2019), D-lactate (Okino et al. 2008), and ectoine (Becker et al. 
2013). The production titers for these compounds are impressive: L-lysine·HCl 120 g/L; L-
arginine, 92.5 g/L; L-glutamate 116 g/L; L-valine, 150 g/L; L-alanine, 216 g/L; and D-lactate, 
120 g/L. The growing number of engineering tools will further facilitate manipulation of the C. 
glutamicum genetic make-up, expanding the construction of synthetic pathways.  
Exploiting the powerful metabolism of C. glutamicum combined with new synthetic 
pathways is posed to increase production of various chemicals. Cadaverine, 5-aminovaleric acid, 
and glutaric acid are notable examples of L-lysine-derived compounds. Implementing a single 
gene, cadA, in C. glutamicum has enabled very efficient production of cadaverine (Kind and 
Wittmann 2011). Similarly, introduction of the genes davB, and davA has led to successful 
production of 5-aminovaleric acid (Rohles et al. 2016). Finally, implementation of the genes 
davT and davD (or equivalent) has resulted in successful production of glutaric acid via L-lysine 
(Rohles et al. 2018). As C. glutamicum is also known to produce vast amounts of L-glutamate, 
the gadB (or equivalent) gene has been introduced to successfully boost production of gamma-
aminobutyrate (Baritugo et al. 2018). Moreover, as C. glutamicum can be modified to generate 
L-ornithine, the speC gene has been introduced to enable production of putrescine (Schneider 
and Wendisch 2010). Application of C. glutamicum for adipic acid was investigated in papers 
VI and V. 
 
5.5. E. coli  
As E. coli is one of the most genetically amenable microorganisms, it has served as a host for 
producing a myriad of chemicals (Choi et al. 2016). Not surprisingly, the first engineered 
organism for biological production of adipic acid was E. coli (Yu et al. 2014), in which the 
introduction of genes responsible for reverse β-oxidation generated sub-mg/L amounts of adipic 
acid from glucose. Several attempts followed to further increase production of adipic acid 
through reverse β-oxidation in E. coli (Babu et al. 2015; Clomburg et al. 2015; Dellomonaco et 
al. 2011). Notably, glycerol proved much more effective than glucose as feedstock, affording 
greater production titers (Zhao et al. 2018). Moreover, reverse β-oxidation genes from 
Thermobifida proved to be very effective. While glycerol, a sugar alcohol, cannot be directly 
obtained from lignocellulosic materials, production of elevated titers of adipic acid in E. coli 
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from glycerol demonstrated that this could be achieved independently of petroleum. 
Furthermore, production of adipic acid via cis,cis-muconic acid has been demonstrated in E. coli 
using an enoate reductase from C. acetobutylicum (Sun et al. 2018). Introducing enoate reductase 
in E. coli generated nearly 10 times more adipic acid (Sun et al. 2018) than in yeast (Raj et al. 
2018). Even though adipic acid production remained at the sub-g/L scale, this experiment 
demonstrated the possibility of more than one metabolic pathway to produce adipic acid from a 




6. Current production of chemicals and 
compounds using microbes  
Technologies for generating adipic acid have not reached a point, whereby industrial-level 
production using renewable feedstock is feasible. The combination of adipic acid production and 
microbial cell factories is still in its infancy. However, technology for producing other chemicals 
has already matured to an industrial scale. Some examples are discussed hereafter, with the aim 
of showing where adipic acid research and production should proceed. 
 
6.1. Successful examples of cell factories producing chemicals and compounds  
Whereas 1,4-BDO was initially derived only from petroleum, it is now partially produced by 
bacteria. Biobased 1,4-BDO is used for the commercial manufacturing of compostable plastic 
bags, which are hugely popular in Europe (Schilling 2019). From an initial biological production 
of 18 g/L (Yim et al. 2011), continuous strain improvement (Bart and Cavallaro 2015; Barton et 
al. 2014; Beardslee and Picataggio 2012; Burgard et al. 2016; Burgard et al. 2003; Burk 2010; 
Challener 2014) has now led to an estimated output of 200,000–600,000 L of 1,4-BDO from 
glucose (Wehrs et al. 2019), which makes up a significant chunk of the existing 1.3 million ton 
global market (Burk 2010). This example demonstrates that building operational bio-refineries 
can lead to the production of bio-based compounds with real world applications. Many similar 
examples will follow in the future and, although there has not been another success story in 





6.2. Production using combined bio- and chemical-conversion 
Not all steps in bio-based production must be carried out biologically. In certain instances, 
processes that combine biological and chemical approaches can effectively generate chemicals 
from renewable resources. Bioplastics that rely on at least one chemical step in the production 
scheme have already been commercialized. In this category of chemicals, which includes 
bioethanol or polylactic acid (PLA), the monomers or precursor molecules are produced 
biologically, and subsequent conversion to end-products is carried out by chemical means.  
Just as fuel production does not take up the entire petroleum utilization, bioethanol serves 
both as fuel and as a platform chemical for the manufacturing of various consumer products. 
Production of bio-based ethanol is driven largely by the bio-energy sector, as well as the 
cooperation between governments and the energy industry. The two largest producers are the 
U.S.A. and Brazil, and the primary feedstock is sugarcane, switch grass and maize. Ethanol 
produced during conventional yeast fermentation, can undergo additional processes including 
dehydration. Chemical dehydration of ethanol yields ethylene, which is the monomer required in 
the manufacturing of high- or low-density polyethylene (PE). Sometimes, downstream processes 
can be local, i.e., chemical conversion is carried out near the ethanol production site. This is the 
case for the ‘I'm green™’ PE products from Braskem, a Brazilian company, which are produced 
from lignocellulosic ethanol. Localizing ethylene production at the site of yeast fermentation of 
sugarcane simplifies the logistics and shipping, driving down costs. Lignocellulosic ethanol can 
be further converted to ethylene glycol through oxidation of ethylene. Ethylene glycol is a 
constituent of polyethylene terephthalate (PET) bottles. By replacing petroleum-based ethylene 
glycol with lignocellulosic ethylene glycol, 30% (w/w) of a PET bottle is of biological origin. 
This is the case of ‘Plant bottles’ advertised by the Coca-Cola Company. Various co-polymers, 
which are made of more than one monomer, can partially originate from petroleum-based and 
bio-based feedstock (see section 6.3).  
Another example of a product that results from combining biological and chemical 
processes is biodegradable plastic generated from lactic acid as the monomer. Lactic acid 
fermentation is well known and production titers above 200 g/L have been reported (Meng et al. 
2012b). In practice, biologically produced lactic acid can be polymerized to PLA in a chemical 
process known as ring opening polymerization. A similar strategy is employed by NatureWorks 
to produce 150,000 tons of PLA annually (Vink and Davies 2015). PLA is currently used in 
variety of consumer products, including coffee capsules, utensils, tea bags, food packaging, and 
many others.  
 
6.3. Mixing bio-based and petroleum-based resources 
Products of a partially chemical and partially biological origin encompass various compounds, 
including the polyamides nylon-5,10, nylon-4,10, and nylon-6,10. These polymers require a 
diamine and a diacid for their production. While theoretically it should be possible, production 
using only bio-based monomers has not yet been realized. Nylon-5,10 is a polyamide comprised 
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of 1,5-diaminopentane (also known also as cadaverine) and decanedioic acid (known also as 
sebacic acid) (Kind et al. 2014). It is produced from petroleum-derived sebacic acid and bio-
based cadaverine and is employed for example for toothbrush production in China (Kyulavska et 
al. 2019). Cadaverine fermentation has been widely successful in Asia and Europe using 
engineered C. glutamicum strains. Sebacic acid, in theory, can be produced biologically through 
microbial castor oil fermentation (Jeon et al. 2019). Accordingly, nylon-5,10 could be 
manufactured entirely from biological feedstocks (Kind et al. 2014). Instead, biologically 
produced sebacic acid has been utilized mostly with 1,4-diaminobutane (putrescine) for the 
synthesis of nylon-4,10. In practice, castor oil is converted to sebacic acid and polymerized with 
petroleum-derived putrescine. This is commercially sold under the brand name EcoPaXX® by 
the Dutch company DSM. While the use of C. glutamicum for putrescine production has been 
quite successful (Schneider and Wendisch 2010), the technology has not been taken up by the 
industry to the best of my knowledge. Successful technology transfer of biological putrescine 
production would allow the generation of nylon-4,10 entirely from biological feedstock. Another 
commercialized product consisting of bio-based sebacic acid is nylon-6,10, sold under the name 
Ultramid® by BASF. In this case, 1,6-diaminohexane is petroleum-derived and sebacic acid is 









7. Conclusion  
In my thesis work, enzymatic reactions in multiple metabolic pathways leading to adipic acid 
biosynthesis were investigated. Particularly, I investigated the enzymatic components 
encompassing the L-lysine pathway (papers II and III), the reverse β-oxidation pathway (paper 
IV), and cis,cis-muconic acid reduction (paper V). Selecting the pathway, host organism, and 
enzymes for adipic acid biosynthesis was addressed in paper I. Investigation of combining 
different pathways and host strains was addressed in papers IV and V. Various tools including 
the recombinant technology (papers IV and V), analytical chemistry (papers IV and V), and 
computational chemistry (papers II, III, and V) were used in my thesis. 
Comprehensively mapping out the enzyme components and metabolic pathways leading 
up to adipic acid revealed similarities and differences in metabolic engineering strategies (paper 
I). Glycerol and palm oil, rather than glucose, were observed as preferred carbon sources. 
Multiple pathways including the alternative L-lysine pathway converged at trans-2-hexenedioic 
acid (papers I and II). In paper II, the binding pocket of Oye1 and E. coli NemA were 
determined not to be the limiting factor for possible α,β-reduction of 6-amino-trans-2-hexenoic 
acid and trans-2-hexenedioic acid. Both Oye1 and NemA were found capable of forming 
hydrogen bonds with carboxylic acid substrates and binding to them in the correct orientations. 
In paper III, investigation of the deamination reaction illustrated that L-lysine might not be the 
best intermediate for α,β-elimination-assisted conversion. Instead, β-D-lysine was found to be a 
more suitable option, potentially allowing for the generation of 6-amino-trans-2-hexenoic acid.  
In paper IV, C. glutamicum was determined as a feasible production host for 
implementation of the reverse β-oxidation pathway. Enzymes involved in the reverse β-oxidation 
was identified and compared in paper I and selected components were implemented in paper 
IV. Non-decarboxylative condensation of succinyl-CoA and acetyl-CoA was achieved for the 
first time in vivo in C. glutamicum to the best of my knowledge. Biosynthesis of 3-hydroxyadipic 
acid in engineered C. glutamicum was observed. 3-hydroxyadipic acid was identified as a 
potentially useful platform chemical for establishing the bio-based industry concept. Identifying 
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analytical methods capable of quantifying tiny amounts of trans-2-hexenedioic acid and adipic 
acid was very challenging throughout. Near the end of the thesis work, a weak adipic acid signal 
was observed by LC/MS, yet it was considered insufficient to provide convincing proof of 
successful adipic acid biosynthesis. A more sensitive method such as LC-MS/MS would be 
necessary to confirm the presence of adipic acid with greater certainty.  
In paper V, the investigation surrounding the reduction of trans-2-hexenedioic acid covered 
in paper II was revisited. Benzoic acid conversion to cis,cis-muconic acid was confirmed. 
Computational tools were used to investigate Oye family members and enoate reductases. Major 
differences between the two families were identified. Putative reasons for the Oye family 
members lacking the capability to reduce trans-2-hexenedioic acid were elucidated and the 
enoate reductase family was determined to be more feasible for trans-2-hexenedioic acid 
reduction. 
Investigation of enzymes in multiple adipic acid pathways revealed new opportunities for 
biosynthesis of adipic acid. Theoretical consideration for L-lysine pathway is now more 
developed than when it was first introduced. New alternative routes for utilizing L-lysine as 
intermediate is now laid out using either β-D-lysine or aminoadipic acid. C. glutamicum can be 
considered as a new host organism to produce adipic acid in addition to yeast, P. putida, T. fusca, 
and E. coli. Functionality of the reverse β-oxidation pathway in C. glutamicum is demonstrated 






The existing dependence on petroleum-based industrial production, together with its standards 
and practices, has stimulated numerous technological advances aimed at the renewable 
production of platform chemicals for consumer product manufacturing. In such a circular 
economy scenario, plants capture and convert atmospheric carbon dioxide into simple sugars, 
which are then further transformed to platform chemicals.  
The use of engineered organisms as microbial cell factories has already resulted in the 
production of a handful of chemicals, such as bioethanol and 1,4-BDO. Many technical 
challenges have already been overcome, allowing technology readiness to reach a higher level. 
Nevertheless, many challenges still lie ahead, especially with respect to expanding the catalogue 
of chemicals amenable to renewable and sustainable production by other industrial or academic 
entities. One of the remaining challenges is to create suitable microorganisms capable of 
efficiently producing adipic acid. Recent bankruptcy of an adipic acid-producing company, 
Verdezyne, showcases the intrinsic difficulties of developing such technology and processes, and 
bringing them to market. Strengthening cooperation between governments and the industry could 
avoid another setback. Research must be continued not only by identifying better enzymes and 
metabolic pathways, but also by exploring more types of substrates. Use of fatty acids as 
substrates in adipic acid production provided a new opportunity for international cooperation as 
shown also by the location of the Verdezyne plant in Malaysia, a leading palm oil producer. I 
personally wonder whether a different strategy with cheaper substrate and different investor 
partnerships would have faced the same destiny. This is not to criticize the management or the 
technology of said venture, but to envisage a better future for bio-based adipic acid production, 
where opportunities are available on multiple fronts. Multiple pathways, host strains, and 
substrates have already been documented but have not been implemented at the industrial level. 
Seeing multiple options in the commercial market is the ultimate goal. My thesis addresses such 
opportunities by investigating various pathways and host combinations. Continued development 
of bio-based adipic acid production would entail further characterization of the L-lysine 
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pathway, improvement of the reverse β-oxidation pathway, and investigation of enoate reductase 
mechanisms.  
A deeper theoretical understanding of α,β-elimination of β-D-lysine is needed to further 
assess whether the chance of elimination is indeed better than for L-lysine. This requires better 
understanding of MIO-mediated enzymatic processes and, ultimately, the determination of 
whether the reaction proceeds via the E2 mechanism. Only if the E2 mechanism is confirmed, 
can L-lysine be considered as an interesting compound for further studies. If E2 is not identified 
as the reaction mechanism for MIO-mediated enzymes, then β-D-lysine should be investigated 
instead. Similarly, the alternative pathway presented in paper II involves L-2-aminoadipic acid 
as one of the intermediates. The amino group on aminoadipic acid might be more feasible for 
elimination if located in the β position rather than in the α position. Thus, future studies may 
include but should not be limited to D-3-aminoadipic acid as a potential intermediate. Successful 
elimination of the amino group from aminoadipic acid yields trans-2-hexenedioic acid, which is 
a recurring intermediate in the reduction of cis,cis-muconic acid.  
While computational and structural aspects of enoate reductases have been provided, 
more experimental results are required. Reduction of trans-2-hexenedioic acid in C. glutamicum 
should be investigated under additional cultivation conditions. Shifting between aerobic and 
anaerobic conditions during cultivation should be also investigated. Moreover, enoate reductase 
expression needs to be confirmed in C. glutamicum. It is still unknown whether enoate 
reductases can functionally mature in C. glutamicum under the conditions tested. As analytics 
were challenging, improving adipic acid titer will benefit detection and verification. SPE, too, 
would benefit from further optimization.  While reduction of trans-2-hexenedioic acid should be 
investigated further, investigation of 6-amino-trans-2-hexenoic acid reduction requires starting 
from anew. The reaction demonstrated in U.S. patent 7,491,520 could not be experimentally 
confirmed in this work.  As demonstrated in paper V, the differences in structure and reducing 
power between Oyes and enoate reductases, point to the use of the latter rather than the former in 
future studies. Additionally, results provided in paper V cast some doubt on the validity of the 
patent’s claims. While some Oye members can bind to the carboxylic group, reducing power is 
greater in enoate reductases. Additional enzyme candidates should be explored to identify those 
with greater oxygen tolerance.  
Biosynthesis of adipic acid via reverse β-oxidation in C. glutamicum was technically 
achieved, but more challenges lie ahead to improve the titer. First, identification of trans-2-
hexenedioic acid and adipic acid produced by engineered strains using more qualitative 
analytical methods such as LC-MS/MS is required. Alternatively, the SPE protocol can be 
optimized to accommodate a larger cultivation volume, thus increasing the adipic acid 
concentration for analysis and enhancing the removal of impurities. Second, degradation of 3-
oxoadipyl-CoA needs to be blocked by deletion of the pcaF gene. Overall, genome engineering 
as well as pathway improvement are needed. Higher titers will improve the analytical steps as a 
higher concentration of adipic acid augments the chance for correct identification.  
 If theoretically given an opportunity to continue with the project, I would have taken the 
following steps to ameliorate adipic acid production by C. glutamicum: 1) validate adipic acid 
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identity, 2) establish intellectual property, 3) bring in industrial interest for expedited 
development, 4) increase adipic acid titer, yield, and productivity, and 5) establish a 
demonstration plant operation. 
Finally, multiple vendors already exist for commercial bioethanol. The same needs to be true 
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